Abbott beats The Street in Q3 on stronger U.S.Sinaptica’s neurostim treatment for Alzheimer’s wins FDA breakthrough nod.GE Healthcare, AMC Health partner on remote monitoring.Medtronic expands global access to robotic-assisted surgery with three new global indication expansions.FDA clears HeartFlow’s AI-powered analysis tech.Philips Respironics CPAP, BiPAP recall is Class I.Outset Medical unveils TabloCart for Tablo hemodialysis system.Nuwellis appoints new CFO following $11M public offering.Ablation is the next step for Intuitive’s Ion system.“We now offer two next-generation presbyopia-mitigating IOL options, with the PanOptix Trifocal for patients who want to be more spectacle independent at all distances and Vivity for patients who seek to improve their intermediate and near vision, with a monofocal-like visual disturbance profile.”įiled Under: Business/Financial News, Featured, Optical/Ophthalmic Tagged With: Alcon And the way that we kind of see Neuralink versus what we’re doing at Neurable is the difference between getting a prosthetic leg and getting a pair of shoes. “With the introduction of Vivity, Alcon continues to demonstrate our ongoing commitment to growing our IOL portfolio and delivering differentiated innovations that meet surgeon and patient needs,” Alcon North America president Sergio Duplan said in the release. And so in 2015, we spun the company out from the University of Michigan and we started Neurable, and that’s where the company really began. clinical trial data, patients who used the Vivity lens observed a 94% rate of “very good” or “good” vision at distance and 92% very good or good vision at arm’s length. The lens is already available in some European markets, along with Australia, New Zealand and Canada, with the company touting more than 125 million implants of the AcrySof IQ platform around the world so far. ophthalmologists during a September 2020 pilot phase. The IOL received FDA approval in February 2020 and was made available to select U.S. X.WAVE is a full-service agency that builds captivating brand experiences through creative strategy. ophthalmologists for use with patients who are undergoing cataract surgery, according to a news release.ĪcrySof IQ Vivity uses Alcon’s proprietary non-diffractive X-Wave technology, which stretches and shifts light without splitting it to deliver monofocal-quality distance vision, strong intermediate vision and functional near vision. Geneva, Switzerland-based Alcon’s AcrySof IQ Vivity IOL, a presbyopia-mitigating lens, is now available to all U.S. Alcon (NYSE: ALC) announced today that it launched the first and only non-diffractive extended depth of focus intraocular lens in the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |